Nesrine Ben Nasr
Overview
Explore the profile of Nesrine Ben Nasr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yannoutsos A, Fontaine M, Galloula A, Damotte D, Chatellier G, Paterlini-Brechot P, et al.
BMC Cardiovasc Disord
. 2019 Sep;
19(1):212.
PMID: 31519196
Background: Smoking is a strong risk factor for cancer and atherosclerosis. Cancer mortality, especially from lung cancer, overtakes cardiovascular (CV) death rate in patients with peripheral arterial disease (PAD). Only...
2.
Nasr N, Rouault A, Cornillet N, Bruandet M, Beaussier H, Tersen I, et al.
Int J Clin Pharm
. 2018 Nov;
40(6):1490-1500.
PMID: 30478495
Background The benefits of educational programs are recognized in chronic diseases. An education program was designed in our hospital, for hypertensive patients after an acute episode of stroke to prevent...
3.
Lagarde N, Delahaye S, Jeremie A, Nasr N, Guillemain H, Empereur-Mot C, et al.
Mol Inform
. 2017 Jul;
36(10).
PMID: 28671755
Nuclear receptors (NRs) constitute an important class of therapeutic targets. During the last 4 years, we tackled the pharmacological profile assessment of NR ligands for which we constructed the NRLiSt...
4.
Mouhsine H, Guillemain H, Moreau G, Fourati N, Zerrouki C, Baron B, et al.
Sci Rep
. 2017 Jun;
7(1):3424.
PMID: 28611375
TNFα is a homotrimeric pro-inflammatory cytokine, whose direct targeting by protein biotherapies has been an undeniable success for the treatment of chronic inflammatory diseases. Despite many efforts, no orally active...
5.
Lagarde N, Nasr N, Jeremie A, Guillemain H, Laville V, Labib T, et al.
J Med Chem
. 2014 Mar;
57(7):3117-25.
PMID: 24666037
Nuclear receptors (NRs) constitute an important class of drug targets. We created the most exhaustive NR-focused benchmarking database to date, the NRLiSt BDB (NRs ligands and structures benchmarking database). The...
6.
Nasr N, Guillemain H, Lagarde N, Zagury J, Montes M
J Chem Inf Model
. 2013 Jan;
53(2):293-311.
PMID: 23312043
Structure based virtual ligand screening (SBVLS) methods are widely used in drug discovery programs. When several structures of the target are available, protocols based either on single structure docking or...